Terms: = Breast cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4
134 results:
1. Phytochemical Profiling by UHPLC-Q-TOF/MS and Chemopreventive Effect of Aqueous Extract of
Rojas-Armas JP; Palomino-Pacheco M; Arroyo-Acevedo JL; Ortiz-Sánchez JM; Justil-Guerrero HJ; Martínez-Heredia JT; Castro-Luna A; Rodríguez Flores C; Guzmán Duxtan AJ
Molecules; 2024 Mar; 29(6):. PubMed ID: 38543016
[No Abstract] [Full Text] [Related]
2. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
Yang Y; Lee J; Woo CG; Lee OJ; Son SM
Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
[TBL] [Abstract] [Full Text] [Related]
3. SMYD3 Modulates AMPK-mTOR Signaling Balance in cancer Cell Response to DNA Damage.
Lepore Signorile M; Sanese P; Di Nicola E; Fasano C; Forte G; De Marco K; Disciglio V; Latrofa M; Pantaleo A; Varchi G; Del Rio A; Grossi V; Simone C
Cells; 2023 Nov; 12(22):. PubMed ID: 37998381
[TBL] [Abstract] [Full Text] [Related]
4. Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed.
Ghosh P; K M M; Pandey N; Basavan D
Anticancer Drugs; 2023 Nov; 34(10):1085-1093. PubMed ID: 37823283
[TBL] [Abstract] [Full Text] [Related]
5.
Cho CY; Kang SH; Kim BC; Kim TK; Kim JH; Kim M; Sohn Y; Jung HS
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594079
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via tsc2/mTORC1 to promote breast cancer migration and invasion.
Hao C; Sheng Z; Wang W; Feng R; Zheng Y; Xiao Q; Zhang B
Thorac Cancer; 2023 Jun; 14(16):1477-1491. PubMed ID: 37144254
[TBL] [Abstract] [Full Text] [Related]
7. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility.
Kawamura M; Shirota H; Niihori T; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Kikuchi A; Tada H; Shimada M; Kawamorita N; Kanamori M; Sugiyama I; Tsubata M; Ichikawa H; Yasuda J; Furukawa T; Aoki Y; Ishioka C
J Hum Genet; 2023 Jun; 68(6):399-408. PubMed ID: 36804482
[TBL] [Abstract] [Full Text] [Related]
8. mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Cancer Causes Control; 2023 May; 34(5):431-447. PubMed ID: 36790512
[TBL] [Abstract] [Full Text] [Related]
9. Fish Oil and Selenium with Doxorubicin Modulates Expression of Fatty Acid Receptors and Selenoproteins, and Targets Multiple Anti-cancer Signaling in Triple-negative breast cancer Tumors.
Guo CH; Shih MY; Chung CH; Lin YC; Fan CT; Peng CL; Chen PC; Hsia S
Int J Med Sci; 2022; 19(14):2044-2057. PubMed ID: 36483592
[TBL] [Abstract] [Full Text] [Related]
10. AKTs do not translocate to the nucleus upon stimulation but AKT3 can constitutively signal from the nuclear envelope.
Wainstein E; Maik-Rachline G; Blenis J; Seger R
Cell Rep; 2022 Dec; 41(10):111733. PubMed ID: 36476861
[TBL] [Abstract] [Full Text] [Related]
11. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
Caliskan S; Akar OS; Gun S; Kefeli M
Turk Patoloji Derg; 2023; 39(3):212-217. PubMed ID: 36367123
[TBL] [Abstract] [Full Text] [Related]
12. Primary Cutaneous Malignant Perivascular Epithelioid Cell Tumor Mimicking Undifferentiated Pleomorphic Sarcoma: A Report of a Rare Entity.
Neumann NM; Cornelia Ding CK; Borgen A; Corvera CU; North JP; Qorbani A; Horvai AE
Am J Dermatopathol; 2022 Oct; 44(10):768-773. PubMed ID: 36122336
[TBL] [Abstract] [Full Text] [Related]
13. Lipid-Associated Macrophages Are Induced by cancer-Associated Fibroblasts and Mediate Immune Suppression in breast cancer.
Timperi E; Gueguen P; Molgora M; Magagna I; Kieffer Y; Lopez-Lastra S; Sirven P; Baudrin LG; Baulande S; Nicolas A; Champenois G; Meseure D; Vincent-Salomon A; Tardivon A; Laas E; Soumelis V; Colonna M; Mechta-Grigoriou F; Amigorena S; Romano E
Cancer Res; 2022 Sep; 82(18):3291-3306. PubMed ID: 35862581
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in breast cancer.
Stella S; Vitale SR; Massimino M; Motta G; Longhitano C; Lanzafame K; Martorana F; Fazzari C; Vecchio GM; Tirrò E; Inzerilli N; Carciotto R; Manzella L; Caruso M; Vigneri P
Cancer Genomics Proteomics; 2022; 19(4):464-476. PubMed ID: 35732329
[TBL] [Abstract] [Full Text] [Related]
15. Mechanistic Target of Rapamycin (mTOR) Inhibitors.
Wang D; Eisen HJ
Handb Exp Pharmacol; 2022; 272():53-72. PubMed ID: 35091825
[TBL] [Abstract] [Full Text] [Related]
16. Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice.
Huang QJ; Liao GC; Zhuang XR; Yang ML; Yao JJ; Deng JH; Zhang YM; Wang Y; Qi XX; Pan DF; Guan Y; Huang ZY; Zhang FX; Liu ZQ; Lu LL
Acta Pharmacol Sin; 2022 Jul; 43(7):1843-1856. PubMed ID: 34845369
[TBL] [Abstract] [Full Text] [Related]
17. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Herranz C; Mateo F; Baiges A; Ruiz de Garibay G; Junza A; Johnson SR; Miller S; García N; Capellades J; Gómez A; Vidal A; Palomero L; Espín R; Extremera AI; Blommaert E; Revilla-López E; Saez B; Gómez-Ollés S; Ancochea J; Valenzuela C; Alonso T; Ussetti P; Laporta R; Xaubet A; Rodríguez-Portal JA; Montes-Worboys A; Machahua C; Bordas J; Menendez JA; Cruzado JM; Guiteras R; Bontoux C; La Motta C; Noguera-Castells A; Mancino M; Lastra E; Rigo-Bonnin R; Perales JC; Viñals F; Lahiguera A; Zhang X; Cuadras D; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Filippakis H; Hakem R; Gorrini C; Ferrer M; Ugun-Klusek A; Billett E; Radzikowska E; Casanova Á; Molina-Molina M; Roman A; Yanes O; Pujana MA
EMBO Mol Med; 2021 Sep; 13(9):e13929. PubMed ID: 34378323
[TBL] [Abstract] [Full Text] [Related]
18. Heterogeneity and cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue.
Espín R; Baiges A; Blommaert E; Herranz C; Roman A; Saez B; Ancochea J; Valenzuela C; Ussetti P; Laporta R; Rodríguez-Portal JA; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Villar-Piqué A; Diaz-Lucena D; Llorens F; Casanova Á; Molina-Molina M; Plass M; Mateo F; Moss J; Pujana MA
Mol Cancer Res; 2021 Nov; 19(11):1840-1853. PubMed ID: 34312290
[TBL] [Abstract] [Full Text] [Related]
19. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
[TBL] [Abstract] [Full Text] [Related]
20. Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience.
Revilla-López E; Berastegui C; Méndez A; Sáez-Giménez B; Ruiz de Miguel V; López-Meseguer M; Monforte V; Bravo C; Pujana MA; Ramon MA; Gómez-Ollés S; Roman A;
Sci Rep; 2021 May; 11(1):10171. PubMed ID: 33986388
[TBL] [Abstract] [Full Text] [Related]
[Next]
